Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
Eur Urol Oncol 2020 Nov 08;[EPub Ahead of Print], M Rouanne, DF Bajorin, R Hannan, MD Galsky, SB Williams, A Necchi, P Sharma, T PowlesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.